Trials / Not Yet Recruiting
Not Yet RecruitingNCT06393972
The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis
The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis: a Single-arm, Prospective, Phase 2 Trial
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The efficacy and safety of Tofacitinib in patients with glucocorticoid resistant ICIs-related myocarditis: a single-arm, prospective, phase 2 trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tofacitinib 5 MG BID | Tofacitinib 5 MG BID |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2025-11-30
- Completion
- 2026-11-30
- First posted
- 2024-05-01
- Last updated
- 2024-05-01
Source: ClinicalTrials.gov record NCT06393972. Inclusion in this directory is not an endorsement.